Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507748-35-00

Acronym

KT-US-486-0201

Enrollment

Registered

2023-10-05

Start date

2022-11-08

Completion date

2024-05-18

Last updated

2024-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026